Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7181 |
Intermediate Similarity |
NPD1058 |
Discontinued |
0.6905 |
Remote Similarity |
NPD1313 |
Approved |
0.6627 |
Remote Similarity |
NPD2593 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD6074 |
Clinical (unspecified phase) |
0.6625 |
Remote Similarity |
NPD7158 |
Phase 1 |
0.6623 |
Remote Similarity |
NPD870 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD3378 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD1333 |
Phase 3 |
0.6595 |
Remote Similarity |
NPD7023 |
Clinical (unspecified phase) |
0.6568 |
Remote Similarity |
NPD516 |
Clinical (unspecified phase) |
0.6554 |
Remote Similarity |
NPD2930 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD1567 |
Clinical (unspecified phase) |
0.6519 |
Remote Similarity |
NPD4902 |
Discontinued |
0.6517 |
Remote Similarity |
NPD5962 |
Phase 2 |
0.6494 |
Remote Similarity |
NPD2875 |
Clinical (unspecified phase) |
0.6491 |
Remote Similarity |
NPD1015 |
Phase 2 |
0.6491 |
Remote Similarity |
NPD1016 |
Phase 2 |
0.649 |
Remote Similarity |
NPD9408 |
Phase 3 |
0.6486 |
Remote Similarity |
NPD3485 |
Clinical (unspecified phase) |
0.6474 |
Remote Similarity |
NPD1215 |
Discontinued |
0.6471 |
Remote Similarity |
NPD9633 |
Phase 3 |
0.6461 |
Remote Similarity |
NPD3341 |
Clinical (unspecified phase) |
0.646 |
Remote Similarity |
NPD4240 |
Approved |
0.645 |
Remote Similarity |
NPD2927 |
Phase 3 |
0.6429 |
Remote Similarity |
NPD8836 |
Approved |
0.6429 |
Remote Similarity |
NPD248 |
Discontinued |
0.6416 |
Remote Similarity |
NPD5269 |
Clinical (unspecified phase) |
0.6409 |
Remote Similarity |
NPD2456 |
Phase 2 |
0.6409 |
Remote Similarity |
NPD2457 |
Phase 2 |
0.6406 |
Remote Similarity |
NPD2965 |
Clinical (unspecified phase) |
0.6389 |
Remote Similarity |
NPD4649 |
Clinical (unspecified phase) |
0.6387 |
Remote Similarity |
NPD6129 |
Phase 2 |
0.6379 |
Remote Similarity |
NPD6794 |
Approved |
0.6378 |
Remote Similarity |
NPD3419 |
Clinical (unspecified phase) |
0.6368 |
Remote Similarity |
NPD6816 |
Phase 3 |
0.6344 |
Remote Similarity |
NPD4615 |
Phase 2 |
0.6344 |
Remote Similarity |
NPD7722 |
Suspended |
0.6343 |
Remote Similarity |
NPD2333 |
Discontinued |
0.6333 |
Remote Similarity |
NPD5508 |
Phase 1 |
0.6322 |
Remote Similarity |
NPD8120 |
Approved |
0.6322 |
Remote Similarity |
NPD8121 |
Phase 3 |
0.6313 |
Remote Similarity |
NPD7111 |
Discontinued |
0.6292 |
Remote Similarity |
NPD3799 |
Suspended |
0.6292 |
Remote Similarity |
NPD7006 |
Approved |
0.629 |
Remote Similarity |
NPD6761 |
Discontinued |
0.6289 |
Remote Similarity |
NPD7323 |
Phase 2 |
0.6286 |
Remote Similarity |
NPD2647 |
Phase 3 |
0.6278 |
Remote Similarity |
NPD5730 |
Phase 2 |
0.6278 |
Remote Similarity |
NPD40 |
Phase 2 |
0.6276 |
Remote Similarity |
NPD3860 |
Discontinued |
0.6273 |
Remote Similarity |
NPD3696 |
Approved |
0.6273 |
Remote Similarity |
NPD3695 |
Approved |
0.6272 |
Remote Similarity |
NPD2524 |
Discontinued |
0.6266 |
Remote Similarity |
NPD4763 |
Clinical (unspecified phase) |
0.6263 |
Remote Similarity |
NPD4352 |
Phase 1 |
0.6257 |
Remote Similarity |
NPD6619 |
Phase 3 |
0.6257 |
Remote Similarity |
NPD3431 |
Approved |
0.6257 |
Remote Similarity |
NPD3430 |
Approved |
0.625 |
Remote Similarity |
NPD799 |
Phase 1 |
0.625 |
Remote Similarity |
NPD6721 |
Phase 1 |
0.625 |
Remote Similarity |
NPD2793 |
Discontinued |
0.625 |
Remote Similarity |
NPD2591 |
Phase 2 |
0.6236 |
Remote Similarity |
NPD5996 |
Clinical (unspecified phase) |
0.623 |
Remote Similarity |
NPD5463 |
Clinical (unspecified phase) |
0.6228 |
Remote Similarity |
NPD4568 |
Phase 2 |
0.6222 |
Remote Similarity |
NPD3041 |
Approved |
0.622 |
Remote Similarity |
NPD171 |
Discontinued |
0.6211 |
Remote Similarity |
NPD5462 |
Discontinued |
0.6209 |
Remote Similarity |
NPD2523 |
Phase 2 |
0.6209 |
Remote Similarity |
NPD2526 |
Phase 2 |
0.6199 |
Remote Similarity |
NPD5969 |
Clinical (unspecified phase) |
0.6178 |
Remote Similarity |
NPD6469 |
Phase 3 |
0.6178 |
Remote Similarity |
NPD6468 |
Clinical (unspecified phase) |
0.6173 |
Remote Similarity |
NPD2451 |
Phase 2 |
0.6173 |
Remote Similarity |
NPD2452 |
Phase 2 |
0.6173 |
Remote Similarity |
NPD7445 |
Phase 1 |
0.6173 |
Remote Similarity |
NPD2453 |
Phase 2 |
0.6173 |
Remote Similarity |
NPD2450 |
Phase 2 |
0.617 |
Remote Similarity |
NPD6577 |
Clinical (unspecified phase) |
0.6162 |
Remote Similarity |
NPD6192 |
Phase 3 |
0.6154 |
Remote Similarity |
NPD5012 |
Phase 2 |
0.6145 |
Remote Similarity |
NPD5324 |
Clinical (unspecified phase) |
0.6142 |
Remote Similarity |
NPD4612 |
Discontinued |
0.6136 |
Remote Similarity |
NPD3889 |
Approved |
0.6129 |
Remote Similarity |
NPD7138 |
Phase 2 |
0.6127 |
Remote Similarity |
NPD5300 |
Clinical (unspecified phase) |
0.6122 |
Remote Similarity |
NPD2877 |
Clinical (unspecified phase) |
0.6122 |
Remote Similarity |
NPD2876 |
Phase 3 |
0.612 |
Remote Similarity |
NPD1637 |
Clinical (unspecified phase) |
0.612 |
Remote Similarity |
NPD5806 |
Clinical (unspecified phase) |
0.6118 |
Remote Similarity |
NPD3107 |
Discontinued |
0.6117 |
Remote Similarity |
NPD6849 |
Phase 2 |
0.6117 |
Remote Similarity |
NPD6850 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD7297 |
Phase 2 |
0.6108 |
Remote Similarity |
NPD4182 |
Phase 3 |
0.6108 |
Remote Similarity |
NPD4183 |
Phase 3 |
0.6105 |
Remote Similarity |
NPD546 |
Clinical (unspecified phase) |
0.6105 |
Remote Similarity |
NPD2646 |
Discontinued |
0.6102 |
Remote Similarity |
NPD4213 |
Clinical (unspecified phase) |
0.6102 |
Remote Similarity |
NPD2478 |
Clinical (unspecified phase) |
0.6099 |
Remote Similarity |
NPD1892 |
Phase 2 |
0.6099 |
Remote Similarity |
NPD3409 |
Phase 1 |
0.6099 |
Remote Similarity |
NPD1893 |
Phase 2 |
0.6089 |
Remote Similarity |
NPD6827 |
Clinical (unspecified phase) |
0.6089 |
Remote Similarity |
NPD6828 |
Phase 2 |
0.6087 |
Remote Similarity |
NPD4441 |
Phase 2 |
0.6085 |
Remote Similarity |
NPD2839 |
Phase 2 |
0.6082 |
Remote Similarity |
NPD4318 |
Clinical (unspecified phase) |
0.6082 |
Remote Similarity |
NPD6151 |
Phase 2 |
0.6077 |
Remote Similarity |
NPD5943 |
Clinical (unspecified phase) |
0.6077 |
Remote Similarity |
NPD5843 |
Discontinued |
0.6077 |
Remote Similarity |
NPD2406 |
Clinical (unspecified phase) |
0.6075 |
Remote Similarity |
NPD5684 |
Clinical (unspecified phase) |
0.6075 |
Remote Similarity |
NPD5683 |
Clinical (unspecified phase) |
0.6075 |
Remote Similarity |
NPD5682 |
Phase 3 |
0.6074 |
Remote Similarity |
NPD193 |
Suspended |
0.6073 |
Remote Similarity |
NPD3362 |
Clinical (unspecified phase) |
0.6064 |
Remote Similarity |
NPD2818 |
Discontinued |
0.6061 |
Remote Similarity |
NPD6521 |
Phase 3 |
0.6061 |
Remote Similarity |
NPD6520 |
Phase 3 |
0.6061 |
Remote Similarity |
NPD2824 |
Phase 2 |
0.605 |
Remote Similarity |
NPD4863 |
Approved |
0.6045 |
Remote Similarity |
NPD509 |
Phase 3 |
0.6043 |
Remote Similarity |
NPD6418 |
Phase 1 |
0.6042 |
Remote Similarity |
NPD3830 |
Phase 1 |
0.6036 |
Remote Similarity |
NPD3708 |
Phase 2 |
0.602 |
Remote Similarity |
NPD2364 |
Suspended |
0.6019 |
Remote Similarity |
NPD4854 |
Phase 3 |
0.6011 |
Remote Similarity |
NPD7504 |
Discontinued |
0.601 |
Remote Similarity |
NPD5885 |
Approved |
0.601 |
Remote Similarity |
NPD3905 |
Phase 3 |
0.6 |
Remote Similarity |
NPD185 |
Approved |
0.6 |
Remote Similarity |
NPD4142 |
Discontinued |
0.5989 |
Remote Similarity |
NPD5642 |
Approved |
0.5989 |
Remote Similarity |
NPD2963 |
Phase 1 |
0.5988 |
Remote Similarity |
NPD3612 |
Phase 2 |
0.5988 |
Remote Similarity |
NPD1257 |
Approved |
0.5981 |
Remote Similarity |
NPD6352 |
Phase 2 |
0.5979 |
Remote Similarity |
NPD5145 |
Clinical (unspecified phase) |
0.5978 |
Remote Similarity |
NPD4716 |
Approved |
0.5978 |
Remote Similarity |
NPD702 |
Clinical (unspecified phase) |
0.5976 |
Remote Similarity |
NPD1690 |
Clinical (unspecified phase) |
0.5974 |
Remote Similarity |
NPD306 |
Approved |
0.5969 |
Remote Similarity |
NPD5486 |
Discontinued |
0.5966 |
Remote Similarity |
NPD1288 |
Clinical (unspecified phase) |
0.5964 |
Remote Similarity |
NPD174 |
Discontinued |
0.596 |
Remote Similarity |
NPD8833 |
Approved |
0.596 |
Remote Similarity |
NPD4023 |
Clinical (unspecified phase) |
0.596 |
Remote Similarity |
NPD8831 |
Approved |
0.596 |
Remote Similarity |
NPD6271 |
Approved |
0.5959 |
Remote Similarity |
NPD2880 |
Discontinued |
0.5957 |
Remote Similarity |
NPD3002 |
Clinical (unspecified phase) |
0.5956 |
Remote Similarity |
NPD1272 |
Clinical (unspecified phase) |
0.5955 |
Remote Similarity |
NPD7988 |
Suspended |
0.5951 |
Remote Similarity |
NPD6470 |
Phase 3 |
0.5947 |
Remote Similarity |
NPD7709 |
Discontinued |
0.5946 |
Remote Similarity |
NPD4744 |
Clinical (unspecified phase) |
0.5941 |
Remote Similarity |
NPD7164 |
Discontinued |
0.5941 |
Remote Similarity |
NPD2902 |
Phase 2 |
0.5941 |
Remote Similarity |
NPD2903 |
Clinical (unspecified phase) |
0.5935 |
Remote Similarity |
NPD7502 |
Clinical (unspecified phase) |
0.5932 |
Remote Similarity |
NPD418 |
Approved |
0.593 |
Remote Similarity |
NPD1030 |
Approved |
0.593 |
Remote Similarity |
NPD1027 |
Approved |
0.593 |
Remote Similarity |
NPD1029 |
Clinical (unspecified phase) |
0.5928 |
Remote Similarity |
NPD166 |
Approved |
0.5928 |
Remote Similarity |
NPD250 |
Approved |
0.5928 |
Remote Similarity |
NPD249 |
Approved |
0.5924 |
Remote Similarity |
NPD3432 |
Approved |
0.592 |
Remote Similarity |
NPD4990 |
Clinical (unspecified phase) |
0.592 |
Remote Similarity |
NPD3405 |
Phase 3 |
0.5909 |
Remote Similarity |
NPD7103 |
Approved |
0.5907 |
Remote Similarity |
NPD7935 |
Phase 2 |
0.5907 |
Remote Similarity |
NPD2960 |
Clinical (unspecified phase) |
0.5904 |
Remote Similarity |
NPD5757 |
Discontinued |
0.5897 |
Remote Similarity |
NPD9084 |
Phase 2 |
0.5896 |
Remote Similarity |
NPD2128 |
Phase 1 |
0.5892 |
Remote Similarity |
NPD1873 |
Clinical (unspecified phase) |
0.5891 |
Remote Similarity |
NPD3265 |
Phase 1 |
0.5888 |
Remote Similarity |
NPD2879 |
Approved |
0.5888 |
Remote Similarity |
NPD2881 |
Approved |
0.5888 |
Remote Similarity |
NPD2807 |
Discontinued |
0.5882 |
Remote Similarity |
NPD2318 |
Discontinued |
0.5882 |
Remote Similarity |
NPD548 |
Clinical (unspecified phase) |
0.5879 |
Remote Similarity |
NPD5458 |
Discontinued |
0.5873 |
Remote Similarity |
NPD7394 |
Phase 2 |
0.587 |
Remote Similarity |
NPD2731 |
Phase 2 |
0.587 |
Remote Similarity |
NPD4155 |
Approved |
0.5869 |
Remote Similarity |
NPD8004 |
Discontinued |
0.5868 |
Remote Similarity |
NPD9704 |
Approved |
0.5868 |
Remote Similarity |
NPD3706 |
Clinical (unspecified phase) |
0.5864 |
Remote Similarity |
NPD1658 |
Discontinued |
0.5864 |
Remote Similarity |
NPD9484 |
Clinical (unspecified phase) |
0.5862 |
Remote Similarity |
NPD1303 |
Phase 1 |
0.5862 |
Remote Similarity |
NPD3906 |
Approved |
0.586 |
Remote Similarity |
NPD1895 |
Discontinued |
0.586 |
Remote Similarity |
NPD1674 |
Clinical (unspecified phase) |
0.586 |
Remote Similarity |
NPD1675 |
Phase 1 |
0.5858 |
Remote Similarity |
NPD195 |
Approved |
0.5858
|
Remote Similarity |
NPD186 |
Discovery |